GSK's Dostarlimab Demonstrates Improvement in PFS for Individuals With Endometrial Cancer

Additionally, study results show a clinically meaningful overall survival trend in the overall population among individuals with primary advanced or recurrent disease.

Related Keywords

Copenhagen ,Køavn ,Denmark ,Hesham Abdullah Drsc ,Mansoor Raza Mirza ,Dostarlimab Jemperli ,Copenhagen University Hospital ,European Society For Medical Oncology Virtual Plenary ,Raza Mirza ,European Society ,Medical Oncology Virtual Plenary ,Gynecologic Oncology Annual Meeting ,New England Journal ,